Replication stress, microcephalic primordial dwarfism, and compromised immunity in ATRIP deficient patients
- PMID: 40029331
- PMCID: PMC11874998
- DOI: 10.1084/jem.20241432
Replication stress, microcephalic primordial dwarfism, and compromised immunity in ATRIP deficient patients
Abstract
Ataxia telangiectasia and Rad3-related (ATR) kinase and its interacting protein ATRIP orchestrate the replication stress response. Homozygous splice variants in the ATRIP gene, resulting in ATRIP deficiency, were identified in two patients of independent ancestry with microcephaly, primordial dwarfism, and recurrent infections. The c.829+5G>T patient exhibited lymphopenia, poor vaccine responses, autoimmune features with hemolytic anemia, and neutropenia. Immunophenotyping revealed reduced CD16+/CD56dim NK cells and absent naïve T cells, MAIT cells, and iNKT cells. Lymphocytic defects were characterized by TCR oligoclonality, abnormal class switch recombination, and impaired T cell proliferation. ATRIP deficiency resulted in low-grade ATR activation but impaired CHK1 phosphorylation under genotoxic stress. ATRIP-deficient cells inadequately regulated DNA replication, leading to chromosomal instability, compromised cell cycle control, and impaired cell viability. CRISPR-SelectTIME confirmed reduced cell fitness for both variants. This study establishes ATRIP deficiency as a monogenic cause of microcephalic primordial dwarfism, highlights ATRIP's critical role in protecting immune cells from replication stress, and offers new insights into its canonical functions.
© 2025 Duthoo et al.
Conflict of interest statement
Disclosures: S. Riemann reported grants from Ghent University (predoctoral mandate BOF23/DOC/013), non-financial support from AstraZeneca, and non-financial support from GSK outside the submitted work. L. Jonckheere reported a grant from the Research Foundation—Flanders (FWO) (predoctoral mandate 11J2525N). C.S. Sørensen reported a patent to the European Patent Office, application no. 21816113.1 on CRISPR-Select pending. No other disclosures were reported.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous